Burning Rock Biotech Ltd (BNR)
8.03
-0.20
(-2.43%)
USD |
NASDAQ |
May 16, 16:00
8.20
+0.17
(+2.12%)
After-Hours: 20:00
Burning Rock Biotech Total Liabilities (Quarterly): 38.31M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.31M |
| September 30, 2023 | 41.63M |
| June 30, 2023 | 50.06M |
| March 31, 2023 | 54.03M |
| December 31, 2022 | 62.20M |
| September 30, 2022 | 60.67M |
| June 30, 2022 | 64.02M |
| March 31, 2022 | 71.29M |
| December 31, 2021 | 67.97M |
| Date | Value |
|---|---|
| September 30, 2021 | 56.42M |
| June 30, 2021 | 56.63M |
| March 31, 2021 | 52.98M |
| December 31, 2020 | 37.04M |
| September 30, 2020 | 39.54M |
| June 30, 2020 | 36.50M |
| March 31, 2020 | 25.43M |
| December 31, 2019 | 248.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.43M
Minimum
Mar 2020
248.55M
Maximum
Dec 2019
62.55M
Average
54.03M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 146.72M |
| Shareholders Equity (Quarterly) | 108.40M |
| Current Ratio | 3.357 |